That’s still limited to LLMs. A lot of work being done is not even in any language. It speaks election orbitals and bonding energy. This is used for biomolecular and pharma purposes.
This AI work is normally not classified as “GenAI” which is what I was responding to, and the parent was specifically talking about LLMs. Usually GenAI specifically refers to LLMs as well as image/video creation.
The big data centers aren’t for the most part being built for pharma research.
That’s still limited to LLMs. A lot of work being done is not even in any language. It speaks election orbitals and bonding energy. This is used for biomolecular and pharma purposes.
This AI work is normally not classified as “GenAI” which is what I was responding to, and the parent was specifically talking about LLMs. Usually GenAI specifically refers to LLMs as well as image/video creation.
The big data centers aren’t for the most part being built for pharma research.
Most part, no. Significant chunk, certainly. Here are some of the larger ongoing contracts:
Eli Lilly & Insilico Medicine ($2.75 Billion)
Merck KGaA & Valo Health (Up to $3.0 Billion)
Roche & Manifold Bio (Up to $2.0 Billion)
AbbVie & Gilgamesh Pharmaceuticals (Up to $2.0 Billion)
Novartis & Relation Therapeutics (Up to $1.7 Billion)
Isomorphic Labs (Alphabet) with Eli Lilly & Novartis ($2.9 Billion Combined)
Eli Lilly & NVIDIA ($1 Billion)